BNTX logo

BNTX
BioNTech SE - ADR

19,106
Mkt Cap
$24B
Volume
1M
52W High
$124.00
52W Low
$79.52
PE Ratio
-18.26
BNTX Fundamentals
Price
$95.50
Prev Close
$91.98
Open
$92.75
50D MA
$99.48
Beta
0.87
Avg. Volume
1.75M
EPS (Annual)
-$5.30
P/B
1.06
Rev/Employee
$414,872.02
$5,894.82
Loading...
Loading...
News
all
press releases
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Consensus Recommendation of "Moderate Buy" by Analysts
Shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the eighteen research firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, four have...
MarketBeat·13h ago
News Placeholder
More News
News Placeholder
BioNTech (NASDAQ:BNTX) Stock Price Expected to Rise, Morgan Stanley Analyst Says
Morgan Stanley raised their price target on shares of BioNTech from $125.00 to $126.00 and gave the stock an "overweight" rating in a report on Friday...
MarketBeat·1d ago
News Placeholder
Aberdeen Group plc Lowers Stock Position in BioNTech SE Sponsored ADR $BNTX
Aberdeen Group plc cut its holdings in shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 84.9% during the fourth quarter, according to the company in its most recent Form 13F filing...
MarketBeat·3d ago
News Placeholder
HC Wainwright Issues Negative Estimate for BioNTech Earnings
BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) - HC Wainwright cut their Q1 2026 EPS estimates for BioNTech in a research report issued on Tuesday, March 31st. HC Wainwright analyst R. Burns...
MarketBeat·9d ago
News Placeholder
BioNTech (NASDAQ:BNTX) Given New $130.00 Price Target at HC Wainwright
HC Wainwright cut their price target on shares of BioNTech from $140.00 to $130.00 and set a "buy" rating on the stock in a report on Tuesday...
MarketBeat·11d ago
News Placeholder
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Short Interest Down 20.7% in March
BioNTech SE Sponsored ADR (NASDAQ:BNTX - Get Free Report) was the recipient of a significant decline in short interest in March. As of March 13th, there was short interest totaling 3,537,489 shares...
MarketBeat·14d ago
News Placeholder
BioNTech (NASDAQ:BNTX) Upgraded to Strong-Buy at Truist Financial
Truist Financial upgraded BioNTech to a "strong-buy" rating in a research note on Wednesday...
MarketBeat·16d ago
News Placeholder
BioNTech SE Sponsored ADR $BNTX Shares Bought by SG Americas Securities LLC
SG Americas Securities LLC grew its holdings in shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 1,664.6% in the 4th quarter, according to the company in its most recent 13F filing...
MarketBeat·16d ago
News Placeholder
Hudson Bay Capital Management LP Acquires 55,004 Shares of BioNTech SE Sponsored ADR $BNTX
Hudson Bay Capital Management LP boosted its stake in BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 36.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 205,004 shares of the company's stock after purchasin...
MarketBeat·23d ago
News Placeholder
Groupama Asset Managment Trims Holdings in BioNTech SE Sponsored ADR $BNTX
Groupama Asset Managment reduced its holdings in shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX - Free Report) by 13.4% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 193,402 shares of the company's stock after selling 29,823 shares during the period...
MarketBeat·23d ago
<
1
2
...
>

Latest BNTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.